SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-011408
Filing Date
2020-06-18
Accepted
2020-06-18 17:03:45
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 620369
2 ex31-1.htm EX-31.1 19796
3 ex31-2.htm EX-31.2 19735
4 ex32-1.htm EX-32.1 10388
  Complete submission text file 0001493152-20-011408.txt   3252478

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptix-20200331.xml EX-101.INS 479402
6 XBRL SCHEMA FILE ptix-20200331.xsd EX-101.SCH 45728
7 XBRL CALCULATION FILE ptix-20200331_cal.xml EX-101.CAL 41433
8 XBRL DEFINITION FILE ptix-20200331_def.xml EX-101.DEF 175169
9 XBRL LABEL FILE ptix-20200331_lab.xml EX-101.LAB 315945
10 XBRL PRESENTATION FILE ptix-20200331_pre.xml EX-101.PRE 239928
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 20973376
SIC: 7389 Services-Business Services, NEC